Table 2.
Correlation between the expression of ASPM and clinicopathological features of CA
| Variable | Number | ASPM | Statistical value | |
|---|---|---|---|---|
|
| ||||
| Negative | Positive | |||
| Histologic grade | ||||
| Well differentiated | 15 | 5 | 10 (66.7%) | χ2=0.977 |
| Moderately differentiated | 53 | 22 | 31 (60.38) | P=0.62 |
| Poorly differentiated | 31 | 15 | 16 (51.6%) | |
| Age (year) | ||||
| <50 | 20 | 10 | 10 (50%) | χ2=0.264 |
| ≥50 | 79 | 32 | 47 (59.5%) | P=0.45 |
| Gender | ||||
| Male | 75 | 34 | 41 (54.7%) | χ2=0.637 |
| Female | 24 | 8 | 16 (66.7%) | P=0.349 |
| Stage | ||||
| I+II | 63 | 32 | 31 (49.2%) | χ2=4.07 |
| III+IV | 36 | 10 | 26 (72.2%) | P=0.03 |
| Lymph node metastasis | ||||
| Yes | 33 | 9 | 24 (72.7%) | χ2=3.76 |
| No | 66 | 33 | 33 (50%) | P=0.03 |